Lung cancer

Read more about the patient satisfaction rates, our specialists' expertise, innovations, and wait times for lung cancer treatment.

Paul Baas
Omdat vrijwel alle denkbare behandelmogelijkheden hier aanwezig zijn, kunnen we in een multidisciplinair team de behandelingen aan de ziekte aanpassen.
Prof. dr. Paul Baas Longarts

Patient satisfaction

Patient satisfaction rates are the opinions of our patients on the care and services they received at the Netherlands Cancer Institute. Our patients named expertise, personal care, information, trust, and the possibility to be involved as important aspects in their ratings of the Netherlands Cancer Institute.


Satisfaction rates for patients with lung cancer at the Netherlands Cancer Institute

Patients with lung cancer give the Netherlands Cancer Institute the following ratings

  • 8.9
  • 8.5
  • 8.7
    Personal attention
  • 8.9
    Confidence/ trust
  • 8.8
    Shared decision making
Op De Kelder
"Usually the ailment is central to the treatment, but here the focus is also on psychosocial support."
Dhr. op de Kelder Patient


Expertise is the experience and skill of our specialists, specific to this cancer type. We measure their expertise by keeping records of the numbers of patients treated, the numbers of patients requesting a second opinion, and the types of treatments being delivered.

The following data is based on the year 2015


  • 3381

    patients with lung cancer
  • 1500

    new patients
  • 239

    second opinions

Further division by treatment type

The expertise of our team of specialists is based on the three main treatments: the number of patients receiving surgery, radiation, and/or treatment with cancer drugs. We will give you further insights into our experience per treatment.

Surgical treatments (most common)



  • 63

    resection lung carcinoma
  • 30

    metastasectomy (wedge resection)
  • 9

    mediastinal surgery

The Netherlands Cancer Institute is part of the quality registration audit “Dutch Lung Cancer Audit” which ensures an overview of the quality of care at this and other hospitals. The results are compared to the national average. 

Drug treatments (most common)

  • 303

  • 379

    targeted therapy
  • 302


Many patients at the Netherlands Cancer Institute participate in a clinical trial looking into drug treatments, such as immunotherapy. These patients have not been included in the overview. 

Radiation treatments (most common)

  • 954

    radiation treatments
Koen Hartemink in gesprek (longkanker)
Together with the specialists across the disciplines we prepare a personalized treatment plan for each patient.
Dr. Koen Hartemink Surgeon
14 days

rapid diagnostics

You can usually get rapid dignostics within fourteen days